Literature DB >> 34401138

Effect of caffeine on postoperative bowel movement and defecation after cesarean section.

Mahnaz Narimani Zamanabadi1, Reza Alizadeh2, Farshid Gholami1, Seyed Ahmad Seyed Mehdi1, Mohamad Aryafar1.   

Abstract

INTRODUCTION: and Importance: Inadequate bowel movement after cesarean section (C-section) can delay the intake of solid diet. Coffee is reported to have beneficial effects on bowel motility after the surgery. This study is designed to evaluate the effects of coffee on bowel movement and defecation following C-section.
METHODS: In this randomized clinical trial study, women undergoing elective C-section at the hospital of (XXX) during 2019-2020 were included. Following the surgery, the patients were divided in case (coffee) and control (water) group. At three different interval after the surgery, 111 ml of coffee or water was given to these patients. After the intervention, time of bowel movement, first defecation, body mass index (BMI), age, gestational age, parity and gravidity were recorded and evaluated between the two groups.
RESULTS: Of total 36 patients (18 in study and control group, respectively), the mean age, gravidity, parity, BMI and gestational age was not significantly different, p-value<0.05. The mean onset of bowel movements in case group was 14.56 h and control group was 16.83 h and the first defecation after cesarean section in case and control group was 27.78 and 31.67 h, respectively. The two groups were significantly different in both the terms, p-value = 0.042 and p-value = 0.002, respectively.
CONCLUSION: The postoperative bowel movement and defecation time is shorter with the intake of coffee among patients undergoing C-section.
© 2021 The Authors.

Entities:  

Keywords:  Bowel movement; Cesarean section; Gynecology; Motility; Postoperative; Surgery

Year:  2021        PMID: 34401138      PMCID: PMC8358636          DOI: 10.1016/j.amsu.2021.102674

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


Introduction

Cesarean section (C-section) is one of the most common surgeries in obstetrics and gynecology, which is performed from 58 % in developing countries to 19 % in developed countries [1,2]. Causes of cesarean section include history of previous cesarean section, fetal distress, fetal progression, cephalopelvic disproportion (CPD), and prenatal bleeding [3,4]. Postoperative care following C-section includes proper nutrition and adequate hydration [5]. Nothing by mouth is practiced postoperatively following C-section until the first flatus or bowel movement. A great focus of postoperative diet is to prevent and manage ileus [6,7]. Coffee is a common beverage that is commonly known for its positive neurological and cardiovascular effects [8]. Its beneficial effects in liver diseases, type II diabetes mellitus, Parkinson's disease, constipation, infections and cancer have also been reported [9,10]. Studies have shown that coffee increases bowel motility and improves postoperative gastrointestinal function [11,12]. Nonetheless, intake of coffee is also known for gastroesophageal reflux symptoms [13]. The aim of this study was to evaluate the effects of postoperative coffee intake following C-section on bowel movement and defecation.

Methods

This randomized clinical trial was performed to investigate the effect of coffee on bowel movements and postoperative defecation following cesarean section among patients aged 18–35 years, referred to the hospitals of the (XXX) from June 2019 to June 2020. Written consent was obtained from all the patients before the participation in the study and all the queries were answered by resident doctor or gynecologist. Demographic information including age, history of underlying diseases such as diabetes, hypertension, heart disease, smoking history and gestational diseases including gestational diabetes, gestational hypertension and previous history of miscarriage were recorded. Patients were also asked regarding any known psychological and genetic disease and family and drug history was obtained, if any. Patients with prolonged surgery (more than 1.5 h), sensitive to caffeine and bupivacaine, unwillingness to participate in study, history of irritable bowel syndrome and idiopathic constipation were excluded from the study. Patients under American Society of Anesthesiologists (ASA) class I and II underwent elective C-section with spinal anesthesia using 2.5 cc Marcaine at L4-L5 levels. The patients were divided in two groups. Control groups were provided 111 ml of water, three times a day whereas study group received 111 ml of coffee, three time a day (11am, 3pm and 7pm). The patient took the assigned beverages under the supervision of a trained nurse. The coffee was prepared by coffee machine, Nescafé® Alegria® (Gatwick, Sussex, The United Kingdom). In case of non-adherence or intolerability of the intervention, individuals were excluded from the study. Patients in both groups were matched in terms of age. In the next step, the method of prescribing the drug and the side effects of the drugs for the patient were explained. The patient was monitored by a gynecologist during the treatment period, who also performed caesarean section in the patients. Finally, side effects such as nausea, vomiting, weakness and lethargy, bleeding, mortality were recorded in patients by resident doctor, who was involved in the research. It should be noted that all patients were recommended to walk 5–11 m, 24 h after surgery. The diet was also similar in such that liquid food was given for first 24 h and after 24 h, solid regular food was started. Patients were evaluated for the time of onset of bowel movements and the time of first defecation after cesarean section. Patients were asked to record any discomfort or signs, they would feel or see. The patients were followed up for 48 postoperative hours. The data was statistically analyzed using software SPSS v22 (IBM, USA). The normality of the data was determined using a one-sample Klomogorov-Smirnov test. Student T test and analysis of variance was used for normal data and if not normal, Kruskal-Wallis and Mann-Whitney tests were used. P-value < 0.05 was considered to be statistically significant. This study was approved by the Research Ethics Board of (XXX). Researchregistry6907. The work has been reported in line with the CONSORT criteria [14].

Results

From the total of 36 patients included in the study (18 in each group), the mean age of the patients was 28.08 ± 3.87 years. Table 1 shows that control and study group were not significantly different in terms of age, body mass index, gravidity, parity and gestational age, p-value >0.05, respectively.
Table 1

Mean and standard deviation of demographic and pregnancy variables in the two groups.

VariableGroupNumberMeanStandard-deviationp-value
Age(year)Intervention1828.723.8160.33
Control1827.443.944
Gestational age(week)Intervention1838.610.9160.518
Control1837.780.808
GravidIntervention181.830.9240.264
Control181.500.707
ParityIntervention180.780.8780.084
Control180.330.594
BMI(kg/m2)Intervention1825.621.7890.987
Control1825.341.115
Mean and standard deviation of demographic and pregnancy variables in the two groups. As can be seen in Table 2, the mean onset of bowel movements in case and control group (14.56 vs. 16.83 h) and the first defecation after cesarean section (27.78 vs. 31.67 h) was significantly different, p-value = 0.042 and p-value = 0.002, respectively.
Table 2

Mean and standard deviation of the onset of bowel movements and excretion in the two groups.

VariableGroupNumberMeanStandard-deviationp-value
onset of bowel movementsIntervention1814.562.9750.042
Control1816.833.468
first defecationIntervention1827.783.30.002
Control1831.673.757
Mean and standard deviation of the onset of bowel movements and excretion in the two groups. The patients were further analyzed based on the two age groups, 30 and less than 30 years and more than 30 years. The time of first defecation was significantly different among study and control group among patients aged 30 years or less, p-value = 0.006. The first bowel movement was not significantly correlated with the age among the two groups and first defecation was not significantly different in case and control groups among patients aged more than 30 years, p-value = 0.251(Table 3).
Table 3

Mean and standard deviation of intestinal motility and excretion in the two groups by age.

VariableGroupGroupNumberMeanStandard-deviationp-value
30≥onset of bowel movementsIntervention1215.003.0150.065
Control143.5033.503
first defecationIntervention123.1433.1430.006
Control144.1224.122
30<onset of bowel movementsIntervention62.9442.9440.651
Control42.3802.380
first defecationIntervention63.8993.8990.251
Control41.7081.708
Mean and standard deviation of intestinal motility and excretion in the two groups by age. Based on the gestational age of the patients, the case and control groups were significantly different in terms of first defecation among the patients with 38 or less weeks of gestational period, p-value = 0.002. This group did not have significant difference in terms of first bowel movement, p-value = 0.195, respectively. The gestational age of more than 38 weeks was not associated with bowel movement and defecation, p-value = 0.145 and p-value = 0.148, respectively (Table 4).
Table 4

Mean and standard deviation of intestinal motility and excretion in the two groups based on gestational age.

VariableGroupGroupNumberMeanStandard-deviationp-value
38 weeks≥onset of bowel movementsIntervention914.563.2060.195
Control816.623.068
first defecationIntervention927.672.3450.002
Control832.883.441
38week<onset of bowel movementsIntervention914.562.9200.145
Control1017.003.916
first defecationIntervention927.894.1970.148
Control1030.703.889
Mean and standard deviation of intestinal motility and excretion in the two groups based on gestational age. Based on gravidity, patients were divided in two groups; gravida 1, and gravida 2 or more. Among gravida 1 group, patients in study and control groups had significant difference in terms of first defecation, p-value = 0.008. These patients were not significantly different in terms of first bowel movement, p-value = 0.081. Similarly, among gravida 2 or more groups, the case and control groups were not significantly different in terms of first bowel movement, p-value = 0.43 and first defecation, p-value = 0.253(Table 5).
Table 5

Mean and standard deviation of intestinal motility and excretion in individuals of the two groups based on the number of pregnancies.

VariableGroupGroupNumberMeanStandard-deviationp-value
1onset of bowel movementsIntervention814.753.0120.081
Control1117.553.387
first defecationIntervention827.753.3700.008
Control1133.003.975
2 ≤onset of bowel movementsIntervention1014.403.0980.43
Control715.713.546
first defecationIntervention1027.803.4250.253
Control729.572.299
Mean and standard deviation of intestinal motility and excretion in individuals of the two groups based on the number of pregnancies. Patients without previous pregnancy were significantly different in terms of first defecation, p-value = 0.026, however no such correlation was found for first bowel movement, p = 0.146. Previous pregnancy was not correlated with first bowel movement and first defecation in case and control groups, p-value = 0.295 and p-value = 0.053, respectively (Table 6).
Table 6

Mean and standard deviation of intestinal motility and excretion in individuals of the two groups based on the history of labor.

VariableGroupGroupNumberMeanStandard-deviationp-value
Yesonset of bowel movementsIntervention814.753.0120.146
Control1317.003.464
first defecationIntervention827.753.3700.026
Control1333.084.291
Noonset of bowel movementsIntervention1014.403.0980.295
Control516.403.847
first defecationIntervention1027.803.4250.053
Control520.601.673
Mean and standard deviation of intestinal motility and excretion in individuals of the two groups based on the history of labor. BMI 25 and less was significantly correlated with first defecation in case and control group, p-value = 0.008 however was not correlated with first bowel movement, p-value = 0.051. BMI greater than 25 was not significantly correlated with first bowel movement, p-value = 0.612 and p-value = 0.197, respectively (Table 7).
Table 7

Mean and standard deviation of intestinal motility and excretion in individuals of the two groups based on BMI.

VariableGroupGroupNumberMeanStandard-deviationp-value
25≥onset of bowel movementsIntervention1113.552.9110.051
Control916.783.993
first defecationIntervention1126.733.1650.008
Control931.784.438
25<onset of bowel movementsIntervention716.142.4780.612
Control916.893.100
first defecationIntervention729.432.9920.197
Control931.563.206
Mean and standard deviation of intestinal motility and excretion in individuals of the two groups based on BMI.

Discussion

Our study reported that first bowel movement and first defecation time is significantly reduced (shorter) among women who are given coffee following C-section. Furthermore, patients with gestational age of 38 weeks and shorter, aged 30 years or less, gravida 1, previous pregnancy and BMI 25 kg/m2 or less presented with significantly shorter time of first defecation. In an interventional study conducted by Rabieipour et al., 2018, investigating the effect of coffee on bowel movements after surgery, 111 patients were studied and divided into two groups; coffee and controls. Consumption of coffee was 111 ml at 8, 12 and 21 h after surgery and it was found that the time of onset of bowel movements, hearing of bowel sounds and defecation of the first stool was not different between the two groups. However, first flatulence was significantly shorter in the intervention group (6). These findings are not in line with those reported in ours. Differences in the sample size, demographic variables, comorbid conditions and caffeine addiction could have influenced these outcomes [15]. In a review study by Eamudomkarn et al., it was reported that coffee consumption as a beverage in the postoperative phase causes earlier bowel movements and shorter duration of first flatulence [16]. In an intervention study conducted by Güngördük et al. [17] to investigate the effect of coffee compared to water on bowel function after surgery, it was found that the time available until the first bowel movement, tolerance of solid food, time of first defecation and time of first flatus was significantly shorter in coffee group. Kruse et al. also reported that intake of coffee postoperatively is associated with a shorter time of first bowel movement and first defecation (9). Dulskas, Klimovskij [18] also concluded that caffeinated coffee intake following laparoscopic colectomy reduced the time of first bowel movement whereas tolerance of solid food was shorter in decaffeinated coffee group. The time of first flatus and hospital duration was not significantly different in the two groups. Our study did not evaluate the effects of decaffeinated coffee and parameters like flatulence and ileus were not evaluated in the study. A recent systematic review and meta-analysis by Gkegkes, Minis [19] showed that postoperative intake of coffee shortens the duration of first bowel movement, first flatus and tolerance of solid diet. The study concluded that coffee improves gastrointestinal motility without any postoperative complications. Our findings are based on small sample size and postoperative parameters like vitals and adverse effects of spinal anesthesia were not evaluated in our study. Further studies are therefore required in this field that include these parameters and evaluate the effects of different doses of caffeine.

Conclusion

The findings of this study showed that the mean onset of bowel movements and the first defecation after cesarean section in the intervention group (coffee) was significantly lower than the control group, which had a significant effect among patients under 31 years of age with a history of pregnancy, gestational age less than 38 weeks and BMI less than 25. Therefore, considering the importance of early onset of gastrointestinal movements in people undergoing cesarean section, coffee is a safe and inexpensive method among cesarean section patients. The favorable effects may be more based on demographic and maternity-related parameters. Therefore, studies with a larger sample size are required in this area.

Provenance and peer review

Not commissioned, externally peer-reviewed.

Conflict of interest

The authors deny any conflict of interest in any terms or by any means during the study.

Sources of funding

N/A.

Ethical approval

This study was approved by the Research Ethics Board of Tehran Islamic Azad University of Medical Sciences, Tehran, Iran (IR.IAU.TMU.REC.1399.323). https://ethics.research.ac.ir/ProposalCertificateEn.php?id=172722&Print=true&NoPrintHeader=true&NoPrintFooter=true&NoPrintPageBorder=true&LetterPrint=true. Researchregistry6907.

Consent for publication

Written informed consent was obtained from the patient for publication of this research and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Availability of data and materials

All relevant data and materials are provided with in manuscript. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Funding for your research

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Contributors’ statement page

Dr. Mahnaz Narimani Zamanabadi and Dr.Mohamad Aryafar: conceptualized and designed the study, drafted the initial manuscript, and reviewed and revised the manuscript. Dr. Farshid Gholami and Dr.Reza Alizadeh: Designed the data collection instruments, collected data, carried out the initial analyses, and reviewed and revised the manuscript. Dr. Seyed Ahmad Seyed mehdi: Coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content.

Consent

Not applicable.

Registration of research studies

Name of the registry: Unique Identifying number or registration ID: researchregistry:6907 https://www.researchregistry.com/browse-the-registry#home/?view_2_search=6907&view_2_page=1.

Guarantor

Dr. Mahnaz Narimani Zamanabadi.

Declaration of competing interest

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
  16 in total

1.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  Ann Intern Med       Date:  2010-03-24       Impact factor: 25.391

Review 2.  Cesarean delivery: counseling issues and complication management.

Authors:  Jeffrey D Quinlan; Neil J Murphy
Journal:  Am Fam Physician       Date:  2015-02-01       Impact factor: 3.292

3.  Effects of coffee consumption on gut recovery after surgery of gynecological cancer patients: a randomized controlled trial.

Authors:  Kemal Güngördük; İsa Aykut Özdemir; Özgü Güngördük; Varol Gülseren; Mehmet Gokçü; Muzaffer Sancı
Journal:  Am J Obstet Gynecol       Date:  2016-10-22       Impact factor: 8.661

4.  Does Coffee Intake Reduce Postoperative Ileus After Laparoscopic Elective Colorectal Surgery? A Prospective, Randomized Controlled Study: The Coffee Study.

Authors:  Simone Hasler-Gehrer; Michael Linecker; Andreas Keerl; Juliette Slieker; Alexandre Descloux; Robert Rosenberg; Burkhardt Seifert; Antonio Nocito
Journal:  Dis Colon Rectum       Date:  2019-08       Impact factor: 4.585

5.  Effect of Coffee on the Length of Postoperative Ileus After Elective Laparoscopic Left-Sided Colectomy: A Randomized, Prospective Single-Center Study.

Authors:  Audrius Dulskas; Michail Klimovskij; Marija Vitkauskiene; Narimantas E Samalavicius
Journal:  Dis Colon Rectum       Date:  2015-11       Impact factor: 4.585

Review 6.  Prevalence, causes, and complications of cesarean delivery in Iran: A systematic review and meta-analysis.

Authors:  Mohammad Rafiei; Marzieh Saei Ghare; Malihe Akbari; Faezeh Kiani; Fatemeh Sayehmiri; Koroush Sayehmiri; Reza Vafaee
Journal:  Int J Reprod Biomed       Date:  2018-04

7.  Effects of Prehospital Traige and Diagnosis of ST Segment Elevation Myocardial Infarction on Mortality Rate.

Authors:  Reza Alizadeh; Ziba Aghsaeifard; Mostafa Sadeghi; Parisa Hassani; Peyman Saberian
Journal:  Int J Gen Med       Date:  2020-09-04

8.  Evaluating memory dysfunction after spinal anesthesia among patients undergoing elective surgery: Descriptive-analytical study.

Authors:  Sepideh Vahabi; Arash Karimi; Siavash Beiranvand; Simin Babaei
Journal:  Ann Med Surg (Lond)       Date:  2021-01-20

9.  Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey.

Authors:  Christiane Barthel; Sandra Wiegand; Sylvie Scharl; Michael Scharl; Pascal Frei; Stephan R Vavricka; Michael Fried; Michael Christian Sulz; Nico Wiegand; Gerhard Rogler; Luc Biedermann
Journal:  Nutr J       Date:  2015-08-12       Impact factor: 3.271

10.  Cross-sectional study on hearing loss and auditory reaction time before and after spinal anesthesia with marcaine 0.5% in patients undergoing elective surgery.

Authors:  Sepideh Vahabi; Parvin Veiskarami; Mehdi Roozbahani; Shahrzad Lashani; Behrouz Farzan
Journal:  Ann Med Surg (Lond)       Date:  2020-11-01
View more
  1 in total

1.  Peppermint drop effect on ileus following cesarean section.

Authors:  Seyyedeh Houra Mousavi Vahed; Malihe Afiat; Salmeh Dadgar
Journal:  J Family Med Prim Care       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.